RecruitingNCT07635368
Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection
Sponsor
Rigshospitalet, Denmark
Enrollment
630 participants
Start Date
Apr 21, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This study seeks to identify and test host protein biomarkers and RNA expression profiles in dried blood spot samples as novel diagnostic markers of congenital cytomegalovirus sequelae and to improve the understanding of the pathogenesis of the disease.
Eligibility
Min Age: 0 DaysMax Age: 28 Days
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with congenital cytomegalovirus, cytomegalovirus infections, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 0 Days to 28 Days.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07635368
Related Trials
Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome
NCT065070071 location
Vestibular and Postural Function in an Unselected Group of Children With Sensorineural Hearing Loss
NCT062297171 location
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
NCT07225972
Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
NCT042303561 location
Third Party Viral Specific T-cells (VSTs)
NCT025324524 locations